Literature DB >> 20953814

Potential relevance of low-intensity microembolic signals by TCD monitoring.

G Telman1, E Sprecher, E Kouperberg.   

Abstract

The significance of low-intensity microembolic signals (MES), as well as their relationship with high-intensity MES, has not yet been studied. We monitored MES by TCD in 256 arteries of 229 patients with carotid stenosis. All microemboli were detected automatically without a preliminary set threshold. For those 110 patients who evidenced any emboli, the correlation between the number of high- and low-intensity MES was r = 0.50, p < 0.0001. A statistically significant relationship between both types of MES was found, with a degree of association of 0.42, as assessed by Cohen's kappa. Later occurrence of high-intensity MES based on early low-intensity MES was statistically significant, with a chi-square p = 0.0006 and a degree of association of 0.24, as assessed by Cohen's kappa. There is a significant relationship between low- and high-intensity MES, thereby indicating that many MES routinely rejected because of their low intensity are real.

Entities:  

Mesh:

Year:  2010        PMID: 20953814     DOI: 10.1007/s10072-010-0429-8

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  24 in total

1.  Prevalence and time course of microembolic signals in patients with acute stroke. A prospective study.

Authors:  U Sliwka; A Lingnau; W D Stohlmann; P Schmidt; M Mull; R R Diehl; J Noth
Journal:  Stroke       Date:  1997-02       Impact factor: 7.914

2.  Intercenter agreement in reading Doppler embolic signals. A multicenter international study.

Authors:  H S Markus; R Ackerstaff; V Babikian; C Bladin; D Droste; D Grosset; C Levi; D Russell; M Siebler; C Tegeler
Journal:  Stroke       Date:  1997-07       Impact factor: 7.914

3.  Variability in occurrence of embolic signals in long term transcranial Doppler recordings.

Authors:  D W Droste; W Decker; H J Siemens; M Kaps; G Schulte-Altedorneburg
Journal:  Neurol Res       Date:  1996-02       Impact factor: 2.448

4.  Distribution of artificial cerebral microemboli in stroke patients with patent foramen ovale.

Authors:  Gregory Telman; Efim Kouperberg; Elliot Sprecher; Dorit Goldsher; David Yarnitsky
Journal:  Neurol Res       Date:  2005-01       Impact factor: 2.448

5.  Effect of the distal-balloon protection system on microembolization during carotid stenting.

Authors:  N Al-Mubarak; G S Roubin; J J Vitek; S S Iyer; G New; M B Leon
Journal:  Circulation       Date:  2001-10-23       Impact factor: 29.690

6.  Prevalence and characteristics of intracranial microemboli signals in patients with different types of prosthetic cardiac valves.

Authors:  D Georgiadis; D G Grosset; A Kelman; A Faichney; K R Lees
Journal:  Stroke       Date:  1994-03       Impact factor: 7.914

7.  How good is intercenter agreement in the identification of embolic signals in carotid artery disease?

Authors:  H Markus; J M Bland; G Rose; M Sitzer; M Siebler
Journal:  Stroke       Date:  1996-07       Impact factor: 7.914

8.  Possible determinants of early microembolism after carotid endarterectomy.

Authors:  Jacinda L Stork; Christopher R Levi; Brian R Chambers; Anne L Abbott; Geoffrey A Donnan
Journal:  Stroke       Date:  2002-08       Impact factor: 7.914

9.  Effect of time and cerebrovascular symptoms of the prevalence of microembolic signals in patients with cervical carotid stenosis.

Authors:  A M Forteza; V L Babikian; C Hyde; M Winter; V Pochay
Journal:  Stroke       Date:  1996-04       Impact factor: 7.914

10.  Microembolic signals at 48 hours after stroke onset contribute to new ischaemia within a week.

Authors:  Y Iguchi; K Kimura; K Kobayashi; Y Ueno; K Shibazaki; T Inoue
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-09-10       Impact factor: 10.154

View more
  1 in total

1.  Microembolus detection by transcranial Doppler sonography: review of the literature.

Authors:  Vlasta Vuković-Cvetković
Journal:  Stroke Res Treat       Date:  2011-11-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.